Related Experiment Video
Updated: Jul 28, 2025
Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
Anesthetic management of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A case report
Nilanjana Howbora1, Swaraj J Sonowal1, Tridip J Borah1
1Department of Anaesthesiology, Critical Care and Pain, Dr. Bhubaneswar Barooah Cancer Institute, Guwahati, Assam, India.
Abstract:
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) can significantly influence overall and disease-free survival in selected patients suffering from peritoneal surface malignancies (PSMs). We report here the anaesthetic management of a 52 year old patient of Ca Colon with secondary ovarian and peritoneal deposits. She underwent cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) with curative intent. The advent of CRS/HIPEC gives a promising alternative to conventional treatment modalities but comes with numerous challenges to the anesthesiologist-in view of the metabolic and hemodynamic adjustments-and demands training.
